Li CH, Papkoff H. Preparation and properties of growth hormone from human and monkey pituitary glands. Science 1956;124:1293-1294.
Duchaine D eds. Underground steroid handbook, 1st ed 1983:84pp HLR Technical Books California. .
World Anti-Doping Agency. A brief history of anti-doping, 2005.http://www.wada-ama.org/en/dynamic.ch2?pageCategory_id=20 (accessed March 2005)..
Bowers LD. Analytical advances in detection of performance-enhancing compounds. Clin Chem 1997;43:1299-1304.
World Anti-Doping Agency. The 2005 prohibited list: international standard. http://www.wada-ama.org/rtecontent/document/list_book_2005_en.pdf (accessed March 2005)..
Bamberger M, Yaeger D. Over the edge 1997:62-72 Sports Illustrated April 14.
Fainaru-Wada M, Williams L. Sprinter admitted use of BALCO ‘magic potion’. November testimony to federal grand jury contradicts record-holder’s public denials 2004:A-1 San Francisco Chronicle June 24.
Fryburg DA, Gelfand RA, Barrett EJ. Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans. Am J Physiol 1991;260:E499-E504.[ISI]
Healy ML, Gibney J, Russell-Jones DL, Pentecost C, Croos P, Sonksen PH, et al. High dose growth hormone exerts an anabolic effect at rest and during exercise in endurance-trained athletes. J Clin Endocrinol Metab 2003;88:5221-5226.
Nussey SS, Whitehead SA. Endocrinology: an integrated approach 2001:358pp BIOS Scientific Publishers Limited London. .
Salomon F, Cuneo R, Hesp R, Sonksen P. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989;321:1797-1803.[Abstract]
Hansen TB, Gram J, Bjerre P, Hagen C, Bollerslev J. Body composition in active acromegaly during treatment with octreotide: a double-blind, placebo-controlled cross-over study. Clin Endocrinol (Oxf) 1994;41:323-329.[ISI][Medline] [Order article via Infotrieve]
Tokish JM, Kocher MS, Hawkins RJ. Ergogenic aids: a review of basic science, performance, side effects, and status in sports. Am J Sports Med 2004;32:1543-1553.
Rennie MJ. Claims for the anabolic effects of growth hormone: a case of the Emperor’s new clothes?. Br J Sports Med 2003;37:100-105.
Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med 2004;34:513-554.
Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci U S A 1998;95:15603-15607.
Wallace JD, Cuneo RC, Lundberg PA, Rosen T, Jorgensen JOL, Longobardi S, et al. Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males. J Clin Endocrinol Metab 2000;85:124-133.
Weltman A, Weltman JY, Schurrer R, Evans WS, Veldhuis JD, Rogol AD. Endurance training amplifies the pulsatile release of growth hormone: effects of training intensity. J Appl Physiol 1992;72:2188-2196.
Hartman ML, Faria AC, Vance ML, Johnson ML, Thorner MO, Veldhuis JD. Temporal structure of in vivo growth hormone secretory events in humans. Am J Physiol 1991;260(1 Pt 1):E101-E110.
Albini CH, Quattrin T, Vandlen RL, MacGillivray MH. Quantitation of urinary growth hormone in children with normal and abnormal growth. Pediatr Res 1988;23:89-92.
Wu Z, Bidlingmaier M, Dall R, Strasburger CJ. Detection of doping with human growth hormone. Lancet 1999;353:895.
Thorner MO, Vance ML, Law ERJ, Horvath E, Kovacs K. The anterior pituitary. Wilson JD Foster DW Kronenberg HM Larsen PR eds. Williams textbook of endocrinology, 9th ed 1998:259-263 WB Saunders Philadelphia. .
Banfi G, Marinelli M, Roi GS, Colombini A, Pontillo M, Giacometti M, et al. Growth hormone and insulin-like growth factor I in athletes performing a marathon at 4000 m of altitude. Growth Regul 1994;4:82-86.
Wu RH, St. Louis Y, DiMartino-Nardi J, Wesoly S, Sobel EH, Sherman B, et al. Preservation of physiological growth hormone (GH) secretion in idiopathic short stature after recombinant GH therapy. J Clin Endocrinol Metab 1990;70:1612-1615.
Strasburger C, Wu Z, Pflaum C, Dressendorfer R. Immunofunctional assay of human growth hormone (hGH) in serum: a possible consensus for quantitative hGH measurement. J Clin Endocrinol Metab 1996;81:2613-2620.
Nindl BC, Kraemer WJ, Hymer WC. Immunofunctional vs immunoreactive growth hormone responses after resistance exercise in men and women. Growth Horm IGF Res 2000;10:99-103.
Wallace JD, Cuneo RC, Bidlingmaier M, Lundberg PA, Carlsson L, Boguszewski CL, et al. Changes in non-22-kilodalton (kDa) isoforms of growth hormone (GH) after administration of 22-kDa recombinant human GH in trained adult males. J Clin Endocrinol Metab 2001;86:1731-1737.
Kniess A, Ziegler E, Kratzsch J, Thieme D, Muller RK. Potential parameters for the detection of hGH doping. Anal Bioanal Chem 2003;376:696-700..
Dall R, Longobardi S, Ehrnborg C, Keay N, Rosen T, Jorgensen JOL, et al. The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. J Clin Endocrinol Metab 2000;85:4193-4200.
Clemmons DR, Thisson JP, Maes M, Ketelslegers JM, Underwood BE. Insulin-like growth factor infusion into hypophysectomized or protein deprived rates induces specific IGF binding proteins in serum. Endocrinology 1989;125:2967-2972.
Longobardi S, Keay N, Ehrnborg C, Cittadini A, Rosen T, Dall R, et al. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. J Clin Endocrinol Metab 2000;85:1505-1512.
Kurdy NM, Bowles S, Marsh DR, Davies A, France M. Serology of collagen types I and III in normal healing of tibial shaft fractures. J Orthop Trauma 1998;12:122-126.
Wallace JD, Cuneo RC, Baxter R, Orskov H, Keay N, Pentecost C, et al. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport. J Clin Endocrinol Metab 1999;84:3591-3601.
Kicman AT, Miell JP, Teale JD, Powrie J, Wood PJ, Laidler P, et al. Serum IGF-I and IGF binding proteins 2 and 3 as potential markers of doping with human GH. Clin Endocrinol 1997;47:43-50.
Woitge HW, Friedmann B, Suttner S, Farahmand I, Muller M, Schmidt-Gayk H, et al. Changes in bone turnover induced by aerobic and anaerobic exercise in young males. J Bone Miner Res 1998;13:1797-1804.
Healy M-L, Dall R, Gibney J, Bassett E, Ehrnborg C, Pentecost C, et al. Toward the development of a test for growth hormone (GH) abuse: a study of extreme physiological ranges of GH-dependent markers in 813 elite athletes in the postcompetition setting. J Clin Endocrinol Metab 2005;90:641-649.
Corpas E, Harman SM, Blackman MR. Human growth hormone and human aging. Endocr Rev 1993;14:20-39.
Banfi G, Casari E, Murone M, Bonini P. Discrepancies among commercial kits for assaying growth hormone. Clin Chem 1990;36:402.
Jansson C, Boguszewski C, Rosberg S, Carlsson L, Albertsson-Wikland K. Growth hormone (GH) assays: influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein. Clin Chem 1997;43:950-956.
Blum WF, Breier BH. Radioimmunoassays for IGFs and IGFBPs. Growth Regul 1994;4:11-19.
Abellan R, Ventura R, Pichini S, Pascual JA, Pacifici R, Di Carlo S, et al. Evaluation of immunoassays for the measurement of insulin-like growth factor-I and procollagen type III peptide, indirect biomarkers of recombinant human growth hormone misuse in sport. Clin Chem Lab Med 2005;43:75-85.
Gervasi G, Samy M, Scholler R. Comparison of four human growth hormone (hGH) immunoassay kits and analysis of recognition of circulating forms. Pathol Biol (Paris) 1990;38:912-919.
Leung K-C, Howe C, Gui LY-Y, Trout G, Veldhuis JD, Ho KKY. Physiological and pharmacological regulation of 20-kDa growth hormone. Am J Physiol Endocrinol Metab 2002;283:E836-E843.